Please sign in to follow a disease.
Calcium metabolic disease
MONDO:0005557Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.
Also known as: disorder of calcium metabolism, calcium metabolism disease, calcium metabolism disorder
62 clinical trials for this condition and its sub-types, 5 tagged with Calcium metabolic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Calcium metabolic disease
-
Calcinosis 30 trials · 47 incl. sub-types
3 sub-types
- Calciphylaxis 9 trials Sub-types →
- Nephrocalcinosis 7 trials · 8 incl. sub-types Sub-types →
- Familial tumoral calcinosis 1 trial Sub-types →
-
Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types
2 sub-types
- Autosomal dominant hypocalcemia 1 4 trials
- Autosomal dominant hypocalcemia 2 1 trial
-
Hypercalcemia disease 4 trials · 7 incl. sub-types
3 sub-types
- Hypercalcemia, infantile 2 trials Sub-types →
- Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types Sub-types →
- Humoral hypercalcemia of malignancy 1 trial
-
Calcium-alkali syndrome 0 trials
Most studied deeper sub-types
-
New drug aims to fix calcium levels in rare genetic disease
Disease control OngoingThis study tests a new drug called encaleret against usual treatments for people with a rare genetic condition called autosomal dominant hypocalcemia type 1 (ADH1), which causes low blood calcium and high urine calcium. About 67 participants will receive either encaleret or stand…
Phase 3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New study monitors rare calcium disorder to better understand its long-term effects
Knowledge-focused OngoingThis study is for people with autosomal dominant hypocalcemia types 1 or 2, rare genetic conditions that cause low blood calcium. Researchers will collect past and future health data from 95 participants to learn how the disease changes over time. The goal is to better understand…
Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC